Eagle Asset Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $78.7M | Sell |
|
|||||
|
2021
Q2 | $57.8M | Sell |
|
|||||
|
2021
Q1 | $63.5M | Sell |
|
|||||
|
2020
Q4 | $94.4M | Sell |
|
|||||
|
2020
Q3 | $90.7M | Sell |
|
|||||
|
2020
Q2 | $86.4M | Buy |
|
|||||
|
2020
Q1 | $54.4M | Sell |
|
|||||
|
2019
Q4 | $48.5M | Sell |
|
|||||
|
2019
Q3 | $36.3M | Buy |
|
|||||
|
2019
Q2 | $37.3M | Buy |
|
|||||
|
2019
Q1 | $40.9M | Buy |
|
|||||
|
2018
Q4 | $38.2M | Sell |
|
|||||
|
2018
Q3 | $50.5M | Sell |
|
|||||
|
2018
Q2 | $43.1M | Sell |
|
|||||
|
2018
Q1 | $48M | Sell |
|
|||||
|
2017
Q4 | $52.2M | Sell |
|
|||||
|
2017
Q3 | $47.1M | Sell |
|
|||||
|
2017
Q2 | $38.2M | Buy |
|
|||||
|
2017
Q1 | $31.2M | Buy |
|
|||||
|
2016
Q4 | $30M | Buy |
|
|||||
|
2016
Q3 | $29.2M | Buy |
|
|||||
|
2016
Q2 | $24.6M | Sell |
|
|||||
|
2016
Q1 | $20.5M | Buy |
|